NYSE:BAK

Braskem Competitors

$16.59
+0.13 (+0.79 %)
(As of 04/14/2021 04:15 PM ET)
Add
Compare
Today's Range
$16.41
Now: $16.59
$16.73
50-Day Range
$10.46
MA: $12.92
$16.27
52-Week Range
$6.07
Now: $16.59
$16.73
Volume217,123 shs
Average Volume264,979 shs
Market Capitalization$6.61 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.36

Competitors

Braskem (NYSE:BAK) Vs. WLK, AMRS, NEU, SXT, MEOH, and REGI

Should you be buying BAK stock or one of its competitors? Companies in the industry of "industrial organic chemicals" are considered alternatives and competitors to Braskem, including Westlake Chemical (WLK), Amyris (AMRS), NewMarket (NEU), Sensient Technologies (SXT), Methanex (MEOH), and Renewable Energy Group (REGI).

Westlake Chemical (NYSE:WLK) and Braskem (NYSE:BAK) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Profitability

This table compares Westlake Chemical and Braskem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Westlake Chemical5.14%4.74%2.25%
Braskem-20.56%-962.43%-13.59%

Analyst Recommendations

This is a summary of recent ratings for Westlake Chemical and Braskem, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Westlake Chemical38402.07
Braskem02202.50

Westlake Chemical presently has a consensus price target of $79.5714, indicating a potential downside of 15.10%. Braskem has a consensus price target of $14.00, indicating a potential downside of 15.51%. Given Westlake Chemical's higher possible upside, research analysts plainly believe Westlake Chemical is more favorable than Braskem.

Volatility & Risk

Westlake Chemical has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500. Comparatively, Braskem has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500.

Insider and Institutional Ownership

28.2% of Westlake Chemical shares are held by institutional investors. Comparatively, 0.5% of Braskem shares are held by institutional investors. 73.1% of Westlake Chemical shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Westlake Chemical and Braskem's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Westlake Chemical$8.12 billion1.48$421 million$3.2628.75
Braskem$12.72 billion0.52$-643,890,000.00($1.71)-9.70

Westlake Chemical has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than Westlake Chemical, indicating that it is currently the more affordable of the two stocks.

Summary

Westlake Chemical beats Braskem on 12 of the 14 factors compared between the two stocks.

Amyris (NASDAQ:AMRS) and Braskem (NYSE:BAK) are both mid-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Profitability

This table compares Amyris and Braskem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Amyris-223.41%N/A-149.25%
Braskem-20.56%-962.43%-13.59%

Analyst Recommendations

This is a summary of recent ratings for Amyris and Braskem, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Amyris00503.00
Braskem02202.50

Amyris presently has a consensus price target of $17.87, indicating a potential upside of 11.34%. Braskem has a consensus price target of $14.00, indicating a potential downside of 15.51%. Given Amyris' stronger consensus rating and higher possible upside, research analysts plainly believe Amyris is more favorable than Braskem.

Volatility & Risk

Amyris has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, Braskem has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500.

Insider and Institutional Ownership

43.5% of Amyris shares are held by institutional investors. Comparatively, 0.5% of Braskem shares are held by institutional investors. 39.7% of Amyris shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Amyris and Braskem's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amyris$152.56 million28.75$-242,770,000.00($2.72)-5.90
Braskem$12.72 billion0.52$-643,890,000.00($1.71)-9.70

Amyris has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than Amyris, indicating that it is currently the more affordable of the two stocks.

Summary

Amyris beats Braskem on 8 of the 14 factors compared between the two stocks.

NewMarket (NYSE:NEU) and Braskem (NYSE:BAK) are both mid-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Profitability

This table compares NewMarket and Braskem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NewMarket12.58%37.86%13.54%
Braskem-20.56%-962.43%-13.59%

Analyst Recommendations

This is a summary of recent ratings for NewMarket and Braskem, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NewMarket0000N/A
Braskem02202.50

Braskem has a consensus price target of $14.00, indicating a potential downside of 15.51%. Given Braskem's higher possible upside, analysts plainly believe Braskem is more favorable than NewMarket.

Volatility & Risk

NewMarket has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Comparatively, Braskem has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500.

Insider and Institutional Ownership

55.7% of NewMarket shares are held by institutional investors. Comparatively, 0.5% of Braskem shares are held by institutional investors. 16.9% of NewMarket shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares NewMarket and Braskem's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewMarket$2.19 billion1.92$254.29 millionN/AN/A
Braskem$12.72 billion0.52$-643,890,000.00($1.71)-9.70

NewMarket has higher earnings, but lower revenue than Braskem.

Summary

NewMarket beats Braskem on 8 of the 12 factors compared between the two stocks.

Sensient Technologies (NYSE:SXT) and Braskem (NYSE:BAK) are both mid-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Valuation & Earnings

This table compares Sensient Technologies and Braskem's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensient Technologies$1.32 billion2.55$82.05 million$2.9626.94
Braskem$12.72 billion0.52$-643,890,000.00($1.71)-9.70

Sensient Technologies has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than Sensient Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Sensient Technologies and Braskem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Sensient Technologies5.12%13.65%6.97%
Braskem-20.56%-962.43%-13.59%

Volatility & Risk

Sensient Technologies has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, Braskem has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Sensient Technologies and Braskem, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sensient Technologies00103.00
Braskem02202.50

Sensient Technologies presently has a consensus price target of $70.00, indicating a potential downside of 12.15%. Braskem has a consensus price target of $14.00, indicating a potential downside of 15.51%. Given Sensient Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Sensient Technologies is more favorable than Braskem.

Insider and Institutional Ownership

88.9% of Sensient Technologies shares are held by institutional investors. Comparatively, 0.5% of Braskem shares are held by institutional investors. 0.8% of Sensient Technologies shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Sensient Technologies beats Braskem on 11 of the 14 factors compared between the two stocks.

Methanex (NASDAQ:MEOH) and Braskem (NYSE:BAK) are both mid-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Methanex and Braskem's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Methanex$2.78 billion1.06$87.77 million$0.9341.83
Braskem$12.72 billion0.52$-643,890,000.00($1.71)-9.70

Methanex has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than Methanex, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Methanex and Braskem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Methanex-4.84%-7.82%-2.24%
Braskem-20.56%-962.43%-13.59%

Risk and Volatility

Methanex has a beta of 2.2, indicating that its stock price is 120% more volatile than the S&P 500. Comparatively, Braskem has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Methanex and Braskem, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Methanex25602.31
Braskem02202.50

Methanex presently has a consensus price target of $44.6667, indicating a potential upside of 14.82%. Braskem has a consensus price target of $14.00, indicating a potential downside of 15.51%. Given Methanex's higher possible upside, equities analysts clearly believe Methanex is more favorable than Braskem.

Insider & Institutional Ownership

58.0% of Methanex shares are held by institutional investors. Comparatively, 0.5% of Braskem shares are held by institutional investors. 1.0% of Methanex shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Methanex beats Braskem on 11 of the 14 factors compared between the two stocks.

Renewable Energy Group (NASDAQ:REGI) and Braskem (NYSE:BAK) are both mid-cap oils/energy companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Renewable Energy Group and Braskem's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Renewable Energy Group$2.64 billion1.07$389.73 million$3.7517.05
Braskem$12.72 billion0.52$-643,890,000.00($1.71)-9.70

Renewable Energy Group has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than Renewable Energy Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Renewable Energy Group and Braskem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Renewable Energy Group22.72%13.11%9.25%
Braskem-20.56%-962.43%-13.59%

Risk and Volatility

Renewable Energy Group has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Braskem has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Renewable Energy Group and Braskem, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Renewable Energy Group02802.80
Braskem02202.50

Renewable Energy Group presently has a consensus price target of $89.1250, indicating a potential upside of 39.43%. Braskem has a consensus price target of $14.00, indicating a potential downside of 15.51%. Given Renewable Energy Group's stronger consensus rating and higher possible upside, equities analysts clearly believe Renewable Energy Group is more favorable than Braskem.

Insider & Institutional Ownership

96.2% of Renewable Energy Group shares are held by institutional investors. Comparatively, 0.5% of Braskem shares are held by institutional investors. 3.0% of Renewable Energy Group shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Renewable Energy Group beats Braskem on 12 of the 14 factors compared between the two stocks.


Braskem Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Westlake Chemical logo
WLK
Westlake Chemical
2.1$93.71+2.3%$11.73 billion$8.12 billion31.03Analyst Report
Increase in Short Interest
Analyst Revision
News Coverage
Amyris logo
AMRS
Amyris
1.3$16.05+4.3%$4.20 billion$152.56 million-7.20
NewMarket logo
NEU
NewMarket
1.0$384.81+0.6%$4.18 billion$2.19 billion16.75Upcoming Earnings
News Coverage
Sensient Technologies logo
SXT
Sensient Technologies
1.8$79.75+0.1%$3.37 billion$1.32 billion50.16
Methanex logo
MEOH
Methanex
1.6$38.90+0.9%$2.94 billion$2.78 billion-23.29Unusual Options Activity
Renewable Energy Group logo
REGI
Renewable Energy Group
2.4$63.92+3.9%$2.72 billion$2.64 billion4.62
Codexis logo
CDXS
Codexis
1.1$24.55+1.4%$1.56 billion$68.46 million-70.14Analyst Report
Analyst Revision
Gevo logo
GEVO
Gevo
1.3$7.18+1.1%$1.44 billion$24.49 million-4.40Increase in Short Interest
Gap Up
Green Plains logo
GPRE
Green Plains
1.2$26.28+0.7%$1.17 billion$2.42 billion-9.25Analyst Downgrade
Westlake Chemical Partners logo
WLKP
Westlake Chemical Partners
2.1$25.67+0.1%$902.85 million$1.09 billion13.95Increase in Short Interest
Aemetis logo
AMTX
Aemetis
1.5$22.31+0.6%$608.10 million$202 million-15.94
FutureFuel logo
FF
FutureFuel
1.3$13.69+0.1%$599.72 million$205.23 million5.27
REX American Resources logo
REX
REX American Resources
0.9$85.72+2.4%$501.29 million$418.03 million131.88Decrease in Short Interest
Gap Down
Alto Ingredients logo
PEIX
Alto Ingredients
1.7$5.03+2.6%$344.54 million$1.42 billion-6.21
Green Plains Partners logo
GPP
Green Plains Partners
1.5$12.22+0.5%$282.21 million$82.39 million6.98Analyst Upgrade
TOMI Environmental Solutions logo
TOMZ
TOMI Environmental Solutions
0.0$3.90+0.5%$65.23 million$6.35 million0.00
TANH
Tantech
0.6$1.43+0.4%$50.97 million$49.23 million0.00
CYTH
Cyclo Therapeutics
1.8$7.14+1.1%$45.44 million$1.01 million0.00
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.